Yahoo
Tokyo - Delayed Quote JPY

BML, Inc. (4694.T)

3,780.00 -55.00 (-1.43%)
At close: November 2 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
Name Title Pay Exercised Year Born
Mr. Kensuke Kondo
President & Representative Director -- -- 1966
Mr. Hideaki Osawa
Exec. Officer, Div Mangr of Mktg. & Dept. Mangr of Proposal & Clinical Trial Mktg and Dir -- -- 1964
Mr. Nobuki Arai
VP & Representative Director -- -- 1960
Masami Kondo
Sr.Mag Exec. Offi Div. Mgr of In-Hospital Testing, Dept. Mgr of 2nd In-Hospital Testing and Director -- -- 1965
Mr. Kenji Shibata
Senior Managing Executive Officer, Div Manager of BML Testing Division & Director -- -- 1959
Mr. Yuji Yamashita
Executive Officer, Division Manager of System Division & Director -- -- 1965
Hiroyuki Kigoshi
Managing Executive Officer -- -- --

BML, Inc.

5-21-3 Sendagaya
Shibuya-ku
Tokyo, 151-0051
Japan
81 3 3350 0111 https://www.bml.co.jp
Sector: 
Healthcare
Full Time Employees: 
4,612

Description

BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.

Corporate Governance

BML, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 11, 2026 at 6:30 AM UTC

BML, Inc. Earnings Date

March 30, 2027 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: